Actively Recruiting
LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema
Led by University Hospital, Ghent · Updated on 2024-11-08
80
Participants Needed
1
Research Sites
286 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Lymphedema is defined as a chronic condition, caused by lymphostasis. A major part in the Western world consists of iatrogenic lymphedema caused by surgery to the lymph nodes of the axilla or groin. Prophylactic lymphovenous anastomosis (LVA) could be beneficial in the prevention of lymphedema of the extremities.
CONDITIONS
Official Title
LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female with breast cancer requiring lymph node dissection
- Age between 18 and 99 years
You will not qualify if you...
- Previous lymphedema
- Body mass index (BMI) greater than 35
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UZ GENT
Ghent, Oost-Vlaanderen, Belgium, 9000
Actively Recruiting
Research Team
B
Bernard Depypere, MD
CONTACT
J
Jessie De Kinder
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here